From Skeptic to Informed: What I Learned Before Trying Weight Loss Tablets
24 Views
I used to roll my eyes at weight loss tablets. Years of adverts promising miracle results, celebrity endorsed capsules and "melt fat while you sleep" claims had left me convinced that every pill on the market was either useless or risky.
So when friends started talking about the new prescription tablets approved in the UK this year, my first instinct was to dismiss them. My second instinct, thankfully, was to read the research before making up my mind.
What I found surprised me. Some of my skepticism turned out to be completely justified. Some of it was badly out of date. Here are the seven biggest things I learned before deciding whether tablets were right for me.
Lesson 1: "Weight loss tablets" is far too broad a label
My first mistake was lumping everything together. It turns out there are three very different groups of products hiding under the same name.
The first is prescription GLP1 tablets, the newest and most researched option. The second is older prescription appetite suppressants such as phentermine and diethylpropion. The third is over the counter supplements, which make up most of the adverts I had been scrolling past for years.
That last group is where my skepticism belonged. Supplements like green tea extract, garcinia and raspberry ketones are not regulated as medicines, and independent reviews have found little reliable evidence that they lead to meaningful weight loss. The prescription options were a completely different story.
Lesson 2: The new GLP1 tablets have serious research behind them
GLP1 medicines copy a hormone your gut naturally releases after eating. They slow digestion, help you feel full sooner and quieten the constant food noise many people describe. Until recently, they were mainly available as injections.
In June 2026, the MHRA approved the Wegovy pill, a 25 mg daily tablet of oral semaglutide. In the OASIS 4 trial behind that approval, people lost an average of 13.6% of their body weight over 64 weeks, compared with just 2.2% on placebo.
A couple of months later, in August 2026, the MHRA authorised Foundayo (orforglipron). In its main trial, people on the highest dose lost an average of 11.2% of their body weight over 72 weeks, against 2.1% on placebo. Unlike the Wegovy pill, it can be taken at any time of day, with or without food.
These were not small studies funded by a supplement brand. They were large, long clinical trials reviewed by a national regulator. Learning that shifted my view on Daily Weight Loss Tablets more than anything else.
Lesson 3: Tablets are not automatically better than injections
I assumed a tablet would be the easy, obvious upgrade. The research is more nuanced. On average, weekly injections still produce more weight loss. The Wegovy injection led to around 15% average loss in its key trial, and Mounjaro, which targets two appetite hormones rather than one, reached around 20% at its highest dose.
Tablets make the most sense for people who dislike needles, find weekly pens inconvenient, or want help maintaining weight they have already lost. The MHRA has also confirmed that people on the 2.4 mg Wegovy injection can switch straight to the daily tablet. For anyone chasing the strongest average result, Mounjaro and Wegovy injections remain the most powerful choice.
Lesson 4: Older appetite suppressants still have a place
Before this year, I had only heard of phentermine through vague warnings online. The reality is more balanced. Phentermine and diethylpropion are stimulant appetite suppressants that have been prescribed for decades.
They do work, but more modestly than GLP1 medicines. Studies usually show a few extra kilograms lost compared with diet and exercise alone, with most of the effect in the first weeks. They are typically prescribed for short courses of up to around 12 weeks, and they are not suitable for people with heart disease, high blood pressure, glaucoma or a history of substance misuse.
Used properly, Phentermine & Diethylpropion Tablets UK can give a helpful short term kickstart. My old assumption that they were simply dangerous was unfair. The truth is they are powerful medicines that need the right patient and proper supervision.
Lesson 5: Side effects are real, but usually manageable
I expected the side effects to be either nonexistent, as the adverts suggest, or terrifying, as some forums claim. Neither was accurate.
With GLP1 tablets, the most common problems are digestive: nausea, diarrhoea, constipation and indigestion. They tend to appear early or when the dose goes up, and often settle with time. In the Wegovy pill trial, around 7% of people stopped treatment because of side effects. Rarer risks include gallbladder problems and pancreatitis, which is exactly why a medical assessment matters.
With phentermine and diethylpropion, the common complaints are different: dry mouth, poor sleep, a faster heart rate and feeling restless.
Lesson 6: Tablets help you change habits; they do not replace them
This was the lesson that stuck with me most. Every trial I read tested these medicines alongside a reduced calorie diet and more physical activity. The tablets make healthier choices much easier, but they are not a substitute for them.
I also learned that weight often comes back when treatment stops. Follow up research on semaglutide found many people regained a large share of their lost weight within a year of stopping. That told me the real goal is to use the time on treatment to build habits that last: eating enough protein, staying active, sleeping better and learning how hunger actually feels.
Lesson 7: Where you get your tablets matters as much as which ones
The final lesson was about safety. GLP1 tablets, phentermine and diethylpropion are all prescription only medicines in the UK. They are licensed for adults with a BMI of 30 or above, or 27 or above with a weight related condition such as type 2 diabetes or high blood pressure. Neither the Wegovy pill nor Foundayo is currently available on the NHS for weight loss, so most people access them privately.
That creates a risk. The MHRA has repeatedly warned about fake and unlicensed weight loss products sold through social media and unregulated websites. These can contain the wrong dose or harmful ingredients. A legitimate provider will always ask about your health history, current medications and goals before prescribing anything.
Where I landed
I started this research expecting to confirm my doubts. Instead, I ended up with a more honest picture. Most supplements still deserve the skepticism I gave them. Prescription tablets, on the other hand, are backed by real evidence, come with real but manageable side effects, and work best as part of a wider plan.
The biggest shift was realising that the question is not "do weight loss tablets work?" but "which option suits my body, my health and my lifestyle?" That is a conversation to have with a qualified clinician, not an advert. If you are at the same point I was, a clinician led service such as Weight Medics can help you compare tablets and injections and choose a safe, realistic starting point.
Frequently asked questions
Are prescription weight loss tablets different from supplements?
Yes. Prescription tablets such as the Wegovy pill and Foundayo are licensed medicines tested in large clinical trials and approved by the MHRA. Most supplements are not regulated as medicines and have little reliable evidence behind them.
How much weight do people lose on GLP1 tablets?
In trials, the Wegovy pill led to average weight loss of 13.6% over 64 weeks, while the highest dose of Foundayo led to 11.2% over 72 weeks. Results vary from person to person.
Should I choose tablets or injections?
Injections usually produce more weight loss on average, while tablets suit people who prefer not to inject or want help maintaining results. A clinician can help you weigh up your goals, health and preferences.
Is phentermine safe?
Phentermine can be safe for the right person under medical supervision, usually for short courses of up to around 12 weeks. It is not suitable for people with heart disease, high blood pressure, glaucoma or a history of substance misuse.
Will the weight come back if I stop taking tablets?
It can. Research shows many people regain weight after stopping GLP1 treatment. Building lasting habits around food, activity and sleep while on treatment gives you the best chance of keeping the results.
Can I get weight loss tablets on the NHS?
At the time of writing, the Wegovy pill and Foundayo are not available on the NHS for weight management. They can be prescribed privately after a proper health assessment.
How do I know a provider is legitimate?
A trustworthy provider will be UK registered, ask detailed questions about your health and medications, and involve a qualified prescriber. Avoid anyone selling weight loss medicines without a consultation.